Update: Cancer Immunotherapy Biotech Files for Insolvency
Update (06/12/2019): Following the phase III failure of its immunotherapy drug for colorectal cancer in…
Update (06/12/2019): Following the phase III failure of its immunotherapy drug for colorectal cancer in…
The UK company ViiV Healthcare will begin a phase IIa trial of an antibody licensed…
An experimental HIV therapy being developed by GSK spinoff ViiV Healthcare in partnership with Janssen…
A first-in-class HIV treatment developed by the UK company ViiV Healthcare has suppressed the virus…
The two-drug pill Dovato, developed by the UK company ViiV Healthcare, has been approved as…
DelSiTech is a Finnish company developing injectable silica gel implants that release drugs slowly over…
Vaccines are humanity’s biggest achievement against infectious diseases. But could they defeat HIV, a particularly…
Update (01/10/2019): The scientists behind the study have declared that the results were based on…
Update (04/04/2019): ViiV Healthcare's two-drug HIV treatment, Juluca, has successfully suppressed the HIV virus for…
Two phase III trials conducted by ViiV Healthcare have concluded that a monthly injection of…
For the second time in history, an HIV-positive patient with blood cancer has achieved HIV…
Hookipa Pharma has reached its first milestone in a partnership deal with US-based CAR T…